TEPEZZA
Drug timelines are a Plus or Pro feature.
19 regulatory and trial events tracked for TEPEZZA, covering 2020-01-21 to 2026-03-25. Get the full timeline:
Most recent: EMA Authorised: Tepezza (teprotumumab) — Amgen Europe B.V.
19 regulatory and trial events tracked for TEPEZZA, covering 2020-01-21 to 2026-03-25. Get the full timeline:
Most recent: EMA Authorised: Tepezza (teprotumumab) — Amgen Europe B.V.